225 related articles for article (PubMed ID: 34391538)
1. Manifestations of Human Papillomavirus in the Head and Neck.
Dable C; Nicolli E
Med Clin North Am; 2021 Sep; 105(5):849-858. PubMed ID: 34391538
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
Berman TA; Schiller JT
Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
[TBL] [Abstract][Full Text] [Related]
4. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
Fung N; Faraji F; Kang H; Fakhry C
Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
[TBL] [Abstract][Full Text] [Related]
5. Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers.
Best SR; Niparko KJ; Pai SI
Otolaryngol Clin North Am; 2012 Aug; 45(4):807-22. PubMed ID: 22793854
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of human papillomavirus in head and neck cancers.
Fakhry C; Gillison ML
J Clin Oncol; 2006 Jun; 24(17):2606-11. PubMed ID: 16763272
[TBL] [Abstract][Full Text] [Related]
7. Nutritional Support in Head and Neck Radiotherapy Patients Considering HPV Status.
Brewczyński A; Jabłońska B; Mrowiec S; Składowski K; Rutkowski T
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33375430
[TBL] [Abstract][Full Text] [Related]
8. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
[TBL] [Abstract][Full Text] [Related]
9. The role of human papillomavirus infection in head and neck cancers.
Syrjänen S
Ann Oncol; 2010 Oct; 21 Suppl 7():vii243-5. PubMed ID: 20943622
[TBL] [Abstract][Full Text] [Related]
10. Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study.
Schorr M; Carlson LE; Lau HY; Zhong L; Bultz BD; Waller A; Groff SL; Hao D
Support Care Cancer; 2017 Oct; 25(10):3225-3233. PubMed ID: 28600705
[TBL] [Abstract][Full Text] [Related]
11. HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection.
Timbang MR; Sim MW; Bewley AF; Farwell DG; Mantravadi A; Moore MG
Hum Vaccin Immunother; 2019; 15(7-8):1920-1928. PubMed ID: 31050595
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis.
Gillison ML; Alemany L; Snijders PJ; Chaturvedi A; Steinberg BM; Schwartz S; Castellsagué X
Vaccine; 2012 Nov; 30 Suppl 5():F34-54. PubMed ID: 23199965
[TBL] [Abstract][Full Text] [Related]
13. AHNS series: Do you know your guidelines? Management of head and neck cancer in the era of human papillomavirus: Educating our patients on human papillomavirus.
Guo T; Goldenberg D; Fakhry C
Head Neck; 2017 May; 39(5):833-839. PubMed ID: 28263449
[TBL] [Abstract][Full Text] [Related]
14. 12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers.
Rulach R; Zhou S; Hendry F; Stobo D; James A; Dempsey MF; Grose D; Lamb C; Schipani S; Rizwanullah M; Wilson C; Paterson C
Oral Oncol; 2019 Oct; 97():76-81. PubMed ID: 31437587
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.
Dalianis T
Presse Med; 2014 Dec; 43(12 Pt 2):e429-34. PubMed ID: 25455638
[TBL] [Abstract][Full Text] [Related]
16. [Human papilloma virus in head and neck cancer].
Barry B; Ortholan C
Cancer Radiother; 2014 Oct; 18(5-6):430-3. PubMed ID: 25151649
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and incidence of HPV-related cancers of the head and neck.
Roman BR; Aragones A
J Surg Oncol; 2021 Nov; 124(6):920-922. PubMed ID: 34558067
[TBL] [Abstract][Full Text] [Related]
18. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
[TBL] [Abstract][Full Text] [Related]
19. HPV vaccination in head and neck HPV-related pathologies.
Wierzbicka M; Józefiak A; Jackowska J; Szydłowski J; Goździcka-Józefiak A
Otolaryngol Pol; 2014; 68(4):157-73. PubMed ID: 24981297
[TBL] [Abstract][Full Text] [Related]
20. Practices regarding human Papillomavirus counseling and vaccination in head and neck cancer: a Canadian physician questionnaire.
Anderson S; Isaac A; Jeffery CC; Robinson JL; Isaac DM; Korownyk C; Biron VL; Seikaly H
J Otolaryngol Head Neck Surg; 2017 Oct; 46(1):61. PubMed ID: 29073940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
